Literature DB >> 10631634

Urinary, faecal and sexual dysfunction in patients with multiple sclerosis.

A Hennessey1, N P Robertson, R Swingler, D A Compston.   

Abstract

The prevalence and nature of bladder and bowel dysfunction were examined in a population-based study of 221 patients with multiple sclerosis who returned postal questionnaires. This preliminary investigation was supplemented by personal review which also provided information on sexual dysfunction in 174 and laboratory and urodynamic tests in 152 participants. Thirty of 221 (14%) currently used an indwelling catheter, and 84 of the remaining 190 (44%) reported symptoms of urinary dysfunction, of which the most common were urgency and frequency. Thirteen of 144 (9%) patients had biochemical evidence of renal dysfunction, and 40 of 132 (30%) had infected urine samples. Eleven of 54 patients in whom investigation of upper urinary tract was thought to be appropriate demonstrated abnormalities. Sixty-four of 221 (29%) patients had experienced faecal incontinence, and 120 of 221 (54%) were constipated. Fifty-six of 68 (82%) men and 55 of 106 (52%) women reported a deterioration in sexual activity, the commonest symptoms being erectile failure in men and fatigue in women.

Entities:  

Mesh:

Year:  1999        PMID: 10631634     DOI: 10.1007/s004150050508

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

Review 1.  Constipation in neurological diseases.

Authors:  K Winge; D Rasmussen; L M Werdelin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Metaboreflex activity in multiple sclerosis patients.

Authors:  Elisabetta Marongiu; Sergio Olla; Sara Magnani; Girolamo Palazzolo; Irene Sanna; Filippo Tocco; Maura Marcelli; Andrea Loi; Francesco Corona; Gabriele Mulliri; Alberto Concu; Antonio Crisafulli
Journal:  Eur J Appl Physiol       Date:  2015-10-01       Impact factor: 3.078

3.  Monitoring my multiple sclerosis: a patient-administered health-assessment scale.

Authors:  Elsie E Gulick; Marie Namey; June Halper
Journal:  Int J MS Care       Date:  2011

Review 4.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

5.  Natural history of multiple sclerosis symptoms.

Authors:  Ilya Kister; Tamar E Bacon; Eric Chamot; Amber R Salter; Gary R Cutter; Jennifer T Kalina; Joseph Herbert
Journal:  Int J MS Care       Date:  2013

6.  Advances in the management of neurogenic detrusor overactivity in multiple sclerosis.

Authors:  Gael J Yonnet; Anette S Fjeldstad; Noel G Carlson; John W Rose
Journal:  Int J MS Care       Date:  2013

Review 7.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 8.  A urological challenge: Voiding dysfunction in multiple sclerosis.

Authors:  Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

9.  The cost utility of solifenacin in the treatment of overactive bladder.

Authors:  Leona Hakkaart; Paul Verboom; Richard Phillips; Maiwenn J Al
Journal:  Int Urol Nephrol       Date:  2008-08-15       Impact factor: 2.370

10.  Prevalence of Sexual Dysfunction in Women with Multiple Sclerosis: a Systematic Review and Meta-Analysis.

Authors:  Amirreza Azimi; Sara Hanaei; Mohammad Ali Sahraian; Mehdi Mohammadifar; Sreeram V Ramagopalan; Mahsa Ghajarzadeh
Journal:  Maedica (Buchar)       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.